Table 3 | Determination of I and II in its formulations..

Sample	Method	Manifested by	Taken mg mL⁻¹	Added mg mL⁻¹	Found*		Recovery %	S.D. %
Sample	Method	Manifested by	Taken mg mL⁻¹	Added mg mL⁻¹	Proposed	Official	Recovery %	S.D. %
Motilium 10 mg/tablet	BCG	Janssen Pharmaceutical N.V. **	3.0		2.98	2.97	99.33	0.83
				3.0	6.02	5.96	100.33	0.52
				6.0	9.05	8.95	100.56	0.78
				9.0	12.10	12.07	100.83	1.12
	MO		4.0		>3.96	4.01	99.00	0.63
				4.0	7.95	8.02	99.38	0.85
				8.0	11.93	12.07	99.42	0.46
				12.0	16.05	15.96	100.32	0.58
	TCNE		5.0		4.97	4.95	99.40	0.83
				5.0	9.95	9.85	99.50	0.56
				10.0	15.10	15.15	100.67	0.71
				15.0	20.10	20.25	100.50	0.47
	TCNQ		6.0		5.97	5.96	99.50	0.94
				6.0	12.05	12.07	100.42	1.11
				12.0	18.10	18.20	100.56	0.83
				15.0	20.90	21.25	99.52	0.79

Doxymycine 100 mg/ Capsule	BCG	Nile Co. *** Pharmaceuticals and Chemical Industries N.V.	3.0		2.95	2.98	98.33	0.63
				3.0	5.92	6.03	98.67	0.51
				6.0	8.96	9.04	99.56	0.88
				9.0	12.07	12.11	100.58	1.03
	MO		4.0		3.98	3.98	99.50	0.41
				4.0	8.07	7.96	100.88	0.57
				8.0	11.98	11.95	99.83	0.81
				12.0	16.15	16.05	100.94	0.47
	TCNE		5.0		5.02	4.96	100.40	0.92
				5.0	10.03	9.92	100.30	1.05
				10.0	14.96	15.10	99.73	0.88
				15.0	19.93	20.15	99.65	0.96
	TCNQ		6.0		5.98	6.03	99.67	1.03
				6.0	12.05	11.95	100.42	0.76
				12.0	18.08	17.90	100.44	0.93
				18.0	24.10	24.25	100.42	1.10

*Average of six determinations.
** Turnhoutseweg 30, B-2340 Beerse, Belgium.
*** Cairo, Egypt.

Table 3: Determination of I and II in its formulations using the proposed and official methods.

Goto home»